JPWO2023220502A5 - - Google Patents
Info
- Publication number
- JPWO2023220502A5 JPWO2023220502A5 JP2024566373A JP2024566373A JPWO2023220502A5 JP WO2023220502 A5 JPWO2023220502 A5 JP WO2023220502A5 JP 2024566373 A JP2024566373 A JP 2024566373A JP 2024566373 A JP2024566373 A JP 2024566373A JP WO2023220502 A5 JPWO2023220502 A5 JP WO2023220502A5
- Authority
- JP
- Japan
- Prior art keywords
- aav
- expression construct
- intron
- coding region
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263341201P | 2022-05-12 | 2022-05-12 | |
| US63/341,201 | 2022-05-12 | ||
| PCT/US2023/064152 WO2023220502A1 (en) | 2022-05-12 | 2023-03-10 | Compositions and methods for recombinant parvovirus production |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025516599A JP2025516599A (ja) | 2025-05-30 |
| JPWO2023220502A5 true JPWO2023220502A5 (https=) | 2026-02-03 |
| JP2025516599A5 JP2025516599A5 (https=) | 2026-02-03 |
Family
ID=85781807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024566373A Pending JP2025516599A (ja) | 2022-05-12 | 2023-03-10 | 組換えパルボウイルス生成のための組成物及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230365991A1 (https=) |
| EP (1) | EP4522729A1 (https=) |
| JP (1) | JP2025516599A (https=) |
| KR (1) | KR20250009975A (https=) |
| CN (1) | CN119487183A (https=) |
| AU (1) | AU2023269763A1 (https=) |
| WO (1) | WO2023220502A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024211780A1 (en) * | 2023-04-07 | 2024-10-10 | Regenxbio Inc. | Compositions and methods for recombinant aav production |
| WO2025090962A1 (en) * | 2023-10-25 | 2025-05-01 | Regenxbio Inc. | Compositions and methods for recombinant aav production |
| TW202548023A (zh) * | 2024-03-14 | 2025-12-16 | 美商雅菲納治療公司 | 用於生產重組腺相關病毒的質體系統 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US5945335A (en) * | 1995-11-09 | 1999-08-31 | Avigen, Inc. | Adenovirus helper-free system for producing recombinant AAV virions lacking oncogenic sequences |
| US6114148C1 (en) | 1996-09-20 | 2012-05-01 | Gen Hospital Corp | High level expression of proteins |
| DE60336736D1 (de) | 2002-07-16 | 2011-05-26 | VGX Pharmaceuticals LLC | Codon-optimierte synthetische plasmide |
| US20130095558A1 (en) * | 2011-07-19 | 2013-04-18 | Wenlin Huang | Process for producing recombinant human endostatin adenovirus |
| EP3870148A4 (en) * | 2018-10-25 | 2022-11-09 | Takeda Pharmaceutical Company Limited | AAV TRIPLE PLASMID SYSTEM |
| EP3722434B1 (en) * | 2019-04-12 | 2022-07-27 | Freeline Therapeutics Limited | Plasmid system |
| EP4085143B1 (en) * | 2019-12-31 | 2025-08-13 | Swanbio Therapeutics Limited | Improved aav-abcd1 constructs and use for treatment or prevention of adrenoleukodystrophy (ald) and/or adrenomyeloneuropathy (amn) |
-
2023
- 2023-03-10 KR KR1020247037537A patent/KR20250009975A/ko active Pending
- 2023-03-10 AU AU2023269763A patent/AU2023269763A1/en active Pending
- 2023-03-10 US US18/181,952 patent/US20230365991A1/en active Pending
- 2023-03-10 CN CN202380046040.7A patent/CN119487183A/zh active Pending
- 2023-03-10 WO PCT/US2023/064152 patent/WO2023220502A1/en not_active Ceased
- 2023-03-10 JP JP2024566373A patent/JP2025516599A/ja active Pending
- 2023-03-10 EP EP23714196.5A patent/EP4522729A1/en active Pending